Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: HBV and lymphoma.
Gentile G, Arcaini L, Antonelli G, Martelli M. Gentile G, et al. Among authors: arcaini l. Front Oncol. 2023 Jul 13;13:1236816. doi: 10.3389/fonc.2023.1236816. eCollection 2023. Front Oncol. 2023. PMID: 37519804 Free PMC article. No abstract available.
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.
Zinzani PL, Paulli M, Arcaini L, Della Torre E, Ferrero S, Figuera A, Frigeri F, Martelli M, Sabattini E, Scarpa R, Barosi G. Zinzani PL, et al. Among authors: arcaini l. Hemasphere. 2023 May 23;7(6):e891. doi: 10.1097/HS9.0000000000000891. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37234822 Free PMC article.
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study.
Michelerio A, Tomasini C, Fiandrino G, De Amici M, Varettoni M, Defrancesco I, Cavalloni C, Brazzelli V, Derlino F, Paulli M, Arcaini L, Vassallo C. Michelerio A, et al. Among authors: arcaini l. Front Med (Lausanne). 2023 Aug 8;10:1231003. doi: 10.3389/fmed.2023.1231003. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614953 Free PMC article.
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29].
Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, Ricardi U, Salar A, Stamatopoulos K, Thieblemont C, Wotherspoon A, Ladetto M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Zucca E, et al. Among authors: arcaini l. Ann Oncol. 2023 Mar;34(3):325. doi: 10.1016/j.annonc.2022.11.009. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36529567 Free article. No abstract available.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Ferrero S, Grimaldi D, Arrigoni E, Pironti M, Zaccaria GM, Alessandria B, Genuardi E, De Luca G, Ghislieri M, Tavarozzi R, Di Rocco A, Re A, Stefoni V, Cavallo F, Boccomini C, Balzarotti M, Zilioli V, Moita F, Arcaini L, Lucchini E, Ballerini F, Ferreri AJM, Puccini B, Palumbo GA, Galimberti S, Cortelazzo S, Di Paolo A, Ladetto M. Ferrero S, et al. Among authors: arcaini l. Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504. Blood Adv. 2023. PMID: 37058477 Free PMC article. Clinical Trial.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U, Herhaus P, Benedetti F, Sonnevi K, Hanoun C, Hänel M, Dierlamm J, Pott C, Klapper W, Gözel D, Schmidt C, Unterhalt M, Ladetto M, Hoster E. Dreyling M, et al. Among authors: arcaini l. Lancet. 2024 May 2:S0140-6736(24)00184-3. doi: 10.1016/S0140-6736(24)00184-3. Online ahead of print. Lancet. 2024. PMID: 38705160 Free article.
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms.
Borsani O, Ferretti VV, Casetti IC, Vanni D, Trotti C, Pietra D, De Silvestri A, Arcaini L, Rumi E. Borsani O, et al. Among authors: arcaini l. Res Pract Thromb Haemost. 2023 Feb;7(2):100122. doi: 10.1016/j.rpth.2023.100122. Epub 2023 Mar 15. Res Pract Thromb Haemost. 2023. PMID: 36999122 Free PMC article. No abstract available.
Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy.
Colaneri M, Pieri TC, Roda S, Ricciardi A, Gotti M, Ferrari J, Arcaini L, Rattotti S, Piralla A, Giardina F, Ferrari G, Sacchi P, Zuccaro V, Baldanti F, Bruno R. Colaneri M, et al. Among authors: arcaini l. J Clin Med. 2022 Dec 15;11(24):7452. doi: 10.3390/jcm11247452. J Clin Med. 2022. PMID: 36556068 Free PMC article.
292 results